-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Hold on Treace Medical Concepts, Raises Price Target to $4

Benzinga·07/16/2026 17:06:42
Listen to the news
Truist Securities analyst Richard Newitter maintains Treace Medical Concepts (NASDAQ:TMCI) with a Hold and raises the price target from $2 to $4.